BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8752834)

  • 1. Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores.
    Fleischer AB; Feldman SR; Rapp SR; Reboussin DM; Exum ML; Clark AR; Rajashekhar V
    J Invest Dermatol; 1996 Jul; 107(1):26-9. PubMed ID: 8752834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity and management of psoriasis within primary care.
    Wade AG; Crawford GM; Young D; Leman J; Pumford N
    BMC Fam Pract; 2016 Oct; 17(1):145. PubMed ID: 27737638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of psychic stress with clinical severity and symptoms of psoriatic patients.
    Harvima RJ; Viinamäki H; Harvima IT; Naukkarinen A; Savolainen L; Aalto ML; Horsmanheimo M
    Acta Derm Venereol; 1996 Nov; 76(6):467-71. PubMed ID: 8982414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis.
    Sampogna F; Sera F; Mazzotti E; Pasquini P; Picardi A; Abeni D;
    Arch Dermatol; 2003 Mar; 139(3):353-8; discussion 357. PubMed ID: 12622629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis.
    Gisondi P; Girolomoni G; Sampogna F; Tabolli S; Abeni D
    Eur J Dermatol; 2005; 15(4):279-83. PubMed ID: 16048759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriatic and psoriatic arthritis patients with and without jet-lag: does it matter for disease severity scores? Insights and implications from a pilot, prospective study.
    Damiani G; Bragazzi NL; Garbarino S; Chattu VK; Shapiro CM; Pacifico A; Malagoli P; Pigatto PDM; Conic RRZ; Tiodorovic D; Watad A; Adawi M
    Chronobiol Int; 2019 Dec; 36(12):1733-1740. PubMed ID: 31645138
    [No Abstract]   [Full Text] [Related]  

  • 7. Self-reported psoriasis severity and quality of life assessment at Comano spa.
    Pagliarello C; Calza A; Di Pietro C; Tabolli S
    Eur J Dermatol; 2012; 22(1):111-6. PubMed ID: 22063458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of symptoms experienced by patients with different clinical types of psoriasis.
    Sampogna F; Gisondi P; Melchi CF; Amerio P; Girolomoni G; Abeni D;
    Br J Dermatol; 2004 Sep; 151(3):594-9. PubMed ID: 15377345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective Health Complaints in Individuals with Psoriasis and Psoriatic Arthritis: Associations with the Severity of the Skin Condition and Illness Perceptions - A Cross-Sectional Study.
    Nordbø ECA; Aamodt G; Ihlebæk CM
    Int J Behav Med; 2017 Jun; 24(3):438-446. PubMed ID: 28155081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only : results of the 2005 Spring US National Psoriasis Foundation Survey.
    Ciocon DH; Horn EJ; Kimball AB
    Am J Clin Dermatol; 2008; 9(2):111-7. PubMed ID: 18284265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
    Reich K; Krüger K; Mössner R; Augustin M
    Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran.
    Jamshidi F; Bouzari N; Seirafi H; Farnaghi F; Firooz A
    Arch Iran Med; 2008 Mar; 11(2):162-5. PubMed ID: 18298293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SAPASI is valid and responsive to psoriasis disease severity changes in a multi-center clinical trial.
    Fleischer AB; Feldman SR; Dekle CL
    J Dermatol; 1999 Apr; 26(4):210-5. PubMed ID: 10343464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The self-administered psoriasis area and severity index is valid and reliable.
    Feldman SR; Fleischer AB; Reboussin DM; Rapp SR; Exum ML; Clark AR; Nurre L
    J Invest Dermatol; 1996 Jan; 106(1):183-6. PubMed ID: 8592072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.
    Lebwohl MG; Kavanaugh A; Armstrong AW; Van Voorhees AS
    Am J Clin Dermatol; 2016 Feb; 17(1):87-97. PubMed ID: 26718712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A European subset analysis from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country-specific features: results from psoriasis patients in Spain.
    Puig L; van de Kerkhof PCM; Reich K; Bachelez H; Barker J; Girolomoni G; Paul C
    J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1176-1182. PubMed ID: 28271561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI).
    Mease PJ
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S64-85. PubMed ID: 22588772
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and clinical patterns of psoriatic arthritis in Indian patients with psoriasis.
    Kumar R; Sharma A; Dogra S
    Indian J Dermatol Venereol Leprol; 2014; 80(1):15-23. PubMed ID: 24448118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices.
    Gottlieb AB; Mease PJ; Mark Jackson J; Eisen D; Amy Xia H; Asare C; Stevens SR
    J Dermatolog Treat; 2006; 17(5):279-87. PubMed ID: 17092858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.